List of Quartette drug patents

Quartette is owned by Teva Branded Pharm.

Quartette contains Ethinyl Estradiol; Levonorgestrel.

Quartette has a total of 2 drug patents out of which 0 drug patents have expired.

Quartette was authorised for market use on 28 March, 2013.

Quartette is available in tablet;oral dosage forms.

Quartette can be used as prevention of pregnancy.

The generics of Quartette are possible to be released after 11 March, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8450299 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Oct, 2025

(2 years from now)

US8415332 TEVA BRANDED PHARM Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
Mar, 2029

(6 years from now)

Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient

Market Authorisation Date: 28 March, 2013

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of QUARTETTE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in